Market steady; Teva and Camtek patent cases in focus
March 08, 2009 at 09:26 AM EDT
Israel stocks were little changed on Sunday, led by weakness in Israel Chemicals and offset by a positive move in Teva Pharmaceutical.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|